DK1296669T3 - Kombinationspræparat af omega-3 fedtsyrer og konjugerede linoliesyrer til behandling af immunologisk prægede sygdomsbilleder - Google Patents

Kombinationspræparat af omega-3 fedtsyrer og konjugerede linoliesyrer til behandling af immunologisk prægede sygdomsbilleder

Info

Publication number
DK1296669T3
DK1296669T3 DK01929617T DK01929617T DK1296669T3 DK 1296669 T3 DK1296669 T3 DK 1296669T3 DK 01929617 T DK01929617 T DK 01929617T DK 01929617 T DK01929617 T DK 01929617T DK 1296669 T3 DK1296669 T3 DK 1296669T3
Authority
DK
Denmark
Prior art keywords
omega
acids
immunologically
imaged
treatment
Prior art date
Application number
DK01929617T
Other languages
English (en)
Inventor
Klaus Sommermeyer
Original Assignee
Fresenius Kabi De Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=7640945&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1296669(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Fresenius Kabi De Gmbh filed Critical Fresenius Kabi De Gmbh
Application granted granted Critical
Publication of DK1296669T3 publication Critical patent/DK1296669T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/201—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having one or two double bonds, e.g. oleic, linoleic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56—Materials from animals other than mammals
    • A61K35/60—Fish, e.g. seahorses; Fish eggs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/12—Mucolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Pulmonology (AREA)
  • Dermatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
DK01929617T 2000-05-05 2001-05-03 Kombinationspræparat af omega-3 fedtsyrer og konjugerede linoliesyrer til behandling af immunologisk prægede sygdomsbilleder DK1296669T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE10022001 2000-05-05

Publications (1)

Publication Number Publication Date
DK1296669T3 true DK1296669T3 (da) 2006-04-18

Family

ID=7640945

Family Applications (1)

Application Number Title Priority Date Filing Date
DK01929617T DK1296669T3 (da) 2000-05-05 2001-05-03 Kombinationspræparat af omega-3 fedtsyrer og konjugerede linoliesyrer til behandling af immunologisk prægede sygdomsbilleder

Country Status (7)

Country Link
EP (1) EP1296669B1 (da)
AT (1) ATE312604T1 (da)
AU (1) AU2001256334A1 (da)
DE (1) DE50108392D1 (da)
DK (1) DK1296669T3 (da)
ES (1) ES2250397T3 (da)
WO (1) WO2001085161A1 (da)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10329839A1 (de) * 2003-06-04 2005-01-05 Hogl, Peter Behandlung von Hautkrankheiten
NZ543486A (en) * 2005-11-10 2009-03-31 Fonterra Corporate Res And Dev Compositions of CIS-9, trans-11 conjugated linoleic acid and vaccenic acid and uses thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0637957T3 (da) * 1992-04-28 1997-08-18 Fresenius Ag Anvendelse af en omega-3-fedtsyreholdig emulsion til fremstilling af et lægemiddel til parenteral behandling af betændelsessygdomme
DE4432633C2 (de) * 1994-09-14 1997-07-31 Singer Peter Dr Med Priv Doz Pharmazeutisches Präparat zur lokalen Behandlung von Schuppenflechte, Neurodermitis und Ekzem
GB9621630D0 (en) * 1996-10-17 1996-12-11 Kappa Pharmaceuticals Ltd Treatment of skin disorders
AU728842B2 (en) * 1997-08-18 2001-01-18 South Dakota State University Dairy products with enhanced CLA content

Also Published As

Publication number Publication date
EP1296669B1 (de) 2005-12-14
AU2001256334A1 (en) 2001-11-20
EP1296669A1 (de) 2003-04-02
DE50108392D1 (de) 2006-01-19
ATE312604T1 (de) 2005-12-15
WO2001085161A1 (de) 2001-11-15
ES2250397T3 (es) 2006-04-16

Similar Documents

Publication Publication Date Title
NO20020090L (no) Farmasöytiske og n¶ringsformuleringer inneholdende essensielle fettsyrer og homocystein-senkende midler
HUP0301107A2 (hu) Zsírsavak gyógyhatású kombinációi és alkalmazásuk
DE69212879T2 (de) Magensaftstabile pharmazeutische Formulierungen zur Oral Verbreichung von Gallensäuren
ES2194107T3 (es) Formulaciones farmaceuticas y dieteticas para la profilaxis y tratamiento de trastornos gastrointestinales.
DK0502925T3 (da) præparat til behandling af inflammatoriske tarmlidelser
BR0110664A (pt) Composição de gordura alimentìcia escoável, e, uso de uma combinação de um éster de ácido cìtrico de glicerìdeos parciais de ácido graxo e um sal
WO2001051008A3 (en) Selective activation of a th1 or th2 lymphocyte regulated immune response
RU2003105901A (ru) Противовоспалительное лекарственное средство
DK1296669T3 (da) Kombinationspræparat af omega-3 fedtsyrer og konjugerede linoliesyrer til behandling af immunologisk prægede sygdomsbilleder
FR2843124B1 (fr) Procede de preparation d'acides gras polyinsatures libres et de leurs metabolites d'oxydation
DE60101509D1 (de) Cla-ester
DE60329588D1 (de) Verwendung von epa and dha zur sekundären prevention von schlaganfällen
CA2151476A1 (en) Use of cyclooxygenase inhibitors for the manufacture of a medicament for enhancing uterine blood perfusion
IT1292126B1 (it) Esteri cerosi arricchiti in acidi grassi omega-3 insaturi,loro preparazione ed uso
ES2060440T3 (es) Derivados de acidos 1,4-dihidropiridin-dicarboxilicos aril-quinolil substituidos, procedimiento para su fabricacion y su uso en medicamentos.
MX9203292A (es) Derivados de acidos grasos omega-3 poliinsaturados, su preparacion y aplicacion
ATE387209T1 (de) Oral einnehmbare zubereitung von mistellectinen und verfahren
TH61532S (th) ผ้าอนามัย
ITFO20000009U1 (it) Sistema ed accorgimenti per l'illuminazione delle insegne.
DE502092T1 (de) Orale zusammensetzung fuer die behandlung intestinaler entzuendlicher krankheiten.
TH16788S1 (th) แหวน
TH51132S (th) แหวน
IT1319866B1 (it) Sistema ed accorgimenti per l'illuminazione delle insegne.
TH71420S (th) แผ่นอนามัย
TH63743S (th) แผ่นอนามัย